Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults
Authors
Keywords
Vaccines, T cells, Influenza, Vaccination and immunization, Elderly, Antibody response, Cytokines, Antibodies
Journal
PLoS One
Volume 14, Issue 6, Pages e0216533
Publisher
Public Library of Science (PLoS)
Online
2019-06-06
DOI
10.1371/journal.pone.0216533
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vaccines for the elderly: current use and future challenges
- (2018) Birgit Weinberger Immunity & Ageing
- Humoral and cell-mediated immune responses to H5N1 plant-made virus-like particle vaccine are differentially impacted by alum and GLA-SE adjuvants in a Phase 2 clinical trial
- (2018) Stéphane Pillet et al. npj Vaccines
- Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
- (2017) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
- (2017) Seth J. Zost et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages
- (2017) Alexander I. Makarkov et al. VACCINE
- Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs
- (2017) Nana H. Overgaard et al. VACCINE
- Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro
- (2017) Hilary E. Hendin et al. VACCINE
- AS03- and MF59-Adjuvanted Influenza Vaccines in Children
- (2017) Amanda L. Wilkins et al. Frontiers in Immunology
- A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
- (2016) Stéphane Pillet et al. CLINICAL IMMUNOLOGY
- Aging of the immune system: Focus on inflammation and vaccination
- (2016) Marcello Pinti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Influenza immunology evaluation and correlates of protection: a focus on vaccines
- (2016) Claudia Maria Trombetta et al. Expert Review of Vaccines
- High-dose influenza vaccine in older adults
- (2016) Joyce M. Wang et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain
- (2016) Donald D Raymond et al. NATURE MEDICINE
- The confounded effects of age and exposure history in response to influenza vaccination
- (2016) Ana Mosterín Höpping et al. VACCINE
- T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines
- (2016) Janet E. McElhaney et al. Frontiers in Immunology
- Natural T Cell–mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study
- (2015) Andrew C. Hayward et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inflammaging decreases adaptive and innate immune responses in mice and humans
- (2015) Daniela Frasca et al. BIOGERONTOLOGY
- Generation and characterization of a trackable plant-made influenza H5 virus-like particle (VLP) containing enhanced green fluorescent protein (eGFP)
- (2015) Katie R. Young et al. FASEB JOURNAL
- Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets
- (2015) S. Pillet et al. VACCINE
- Safe vaccination of patients with egg allergy by using live attenuated influenza vaccine
- (2015) Anne Des Roches et al. Journal of Allergy and Clinical Immunology-In Practice
- Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens
- (2014) Nathalie Landry et al. CLINICAL IMMUNOLOGY
- Modeling the Effect of Different Vaccine Effectiveness Estimates on the Number of Vaccine-Prevented Influenza-Associated Hospitalizations in Older Adults
- (2014) Alicia M. Fry et al. CLINICAL INFECTIOUS DISEASES
- Ageing and respiratory infections: The airway of ageing
- (2014) Kamran Haq et al. IMMUNOLOGY LETTERS
- Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children
- (2014) K. G.- I. Mohn et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
- (2014) Carlos A. DiazGranados et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial
- (2014) Juan Carlos Tinoco et al. VACCINE
- Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines
- (2014) Brian J. Ward et al. VACCINE
- Memory CD4 T Cell-Mediated Immunity against Influenza A Virus: More than a Little Helpful
- (2013) K. Kai McKinstry et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
- (2013) Dorothee Kieninger et al. BMC INFECTIOUS DISEASES
- Patients Hospitalized With Laboratory-Confirmed Influenza During the 2010-2011 Influenza Season: Exploring Disease Severity by Virus Type and Subtype
- (2013) S. S. Chaves et al. JOURNAL OF INFECTIOUS DISEASES
- Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses
- (2013) F. Spensieri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination
- (2013) S.-E. Bentebibel et al. Science Translational Medicine
- Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial
- (2013) Peter Tsang et al. VACCINE
- Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008
- (2012) Hong Zhou et al. CLINICAL INFECTIOUS DISEASES
- Egg-allergic patients can be safely vaccinated against influenza
- (2012) Anne Des Roches et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines
- (2012) Janet E. McElhaney et al. VACCINE
- Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children
- (2011) Daniel F. Hoft et al. JOURNAL OF INFECTIOUS DISEASES
- Viral pneumonia
- (2011) Olli Ruuskanen et al. LANCET
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- Humoral and Cell-Mediated Immunity to Pandemic H1N1 Influenza in a Canadian Cohort One Year Post-Pandemic: Implications for Vaccination
- (2011) Lisa E. Wagar et al. PLoS One
- Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis
- (2011) W.E.P. Beyer et al. VACCINE
- Influenza vaccine responses in older adults
- (2010) Janet E. McElhaney AGEING RESEARCH REVIEWS
- Memory CD4 T Cells Direct Protective Responses to Influenza Virus in the Lungs through Helper-Independent Mechanisms
- (2010) J. R. Teijaro et al. JOURNAL OF VIROLOGY
- The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza
- (2010) Marc-André D’Aoust et al. PLANT BIOTECHNOLOGY JOURNAL
- Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
- (2010) Nathalie Landry et al. PLoS One
- Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination
- (2010) Ramu A. Subbramanian et al. VACCINE
- Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza
- (2010) Jianping Lin et al. VACCINE
- Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children
- (2008) B. D. Forrest et al. Clinical and Vaccine Immunology
- Biology of Immune Responses to Vaccines in Elderly Persons
- (2008) Birgit Weinberger et al. CLINICAL INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started